InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Phio Pharmaceuticals Corp.

PHIO Clue Score44
United States Fiscal year ends December CIK 0001533040
$0.92 -5.80% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.92 −46.71% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.0Operating income−9.0Net income−9.0Fiscal year 2017Revenue0.0 −21.1%Operating income−14.1Net income−12.5Fiscal year 2018Revenue0.1 +820.0%Operating income−7.4Net income−7.4Fiscal year 2019Revenue0.0 −84.8%Operating income−9.0Net income−8.9Fiscal year 2020Revenue0.0 −100.0%Operating income−8.8Net income−8.8Fiscal year 2021Operating income−13.5Net income−13.3EPS, diluted−12.43Fiscal year 2022Operating income−11.5Net income−11.5EPS, diluted−10.10Fiscal year 2023Operating income−10.8Net income−10.8EPS, diluted−46.76Fiscal year 2024Operating income−7.4Net income−7.2EPS, diluted−9.08Fiscal year 2025Operating income−9.2Net income−8.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 0.0 0.1 0.0 0.0 n/a n/a n/a n/a n/a
Growth −21.1% +820.0% −84.8% −100.0%
Operating income −9.0 −14.1 −7.4 −9.0 −8.8 −13.5 −11.5 −10.8 −7.4 −9.2
Net income −9.0 −12.5 −7.4 −8.9 −8.8 −13.3 −11.5 −10.8 −7.2 −8.7
Growth
EPS, diluted n/a n/a n/a n/a n/a −12.43 −10.10 −46.76 −9.08 n/a

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−47,447.4%Net margin−47,336.8%Free cash flow margin−40,863.2%Fiscal year 2017Operating margin−93,746.7%Net margin−83,013.3%Free cash flow margin−64,780.0%Fiscal year 2018Operating margin−5,336.2%Net margin−5,333.3%Free cash flow margin−5,452.9%Fiscal year 2019Operating margin−42,795.2%Net margin−42,419.0%Free cash flow margin−41,509.5%Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −47,447.4% −93,746.7% −5,336.2% −42,795.2% n/a n/a n/a n/a n/a n/a
Net margin −47,336.8% −83,013.3% −5,333.3% −42,419.0% n/a n/a n/a n/a n/a n/a
Free cash flow margin −40,863.2% −64,780.0% −5,452.9% −41,509.5% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−7.8Capital expenditure−0.0Free cash flow−7.8Fiscal year 2017Operating cash flow−9.5Capital expenditure−0.2Free cash flow−9.7Fiscal year 2018Operating cash flow−7.5Capital expenditure−0.0Free cash flow−7.5Fiscal year 2019Operating cash flow−8.6Capital expenditure−0.1Free cash flow−8.7Fiscal year 2020Operating cash flow−8.8Capital expenditure−0.0Free cash flow−8.8Fiscal year 2021Operating cash flow−11.9Capital expenditure−0.1Free cash flow−11.9Fiscal year 2022Operating cash flow−12.1Capital expenditure−0.1Free cash flow−12.3Fiscal year 2023Operating cash flow−10.7Capital expenditure−0.0Free cash flow−10.8Fiscal year 2024Operating cash flow−7.1Capital expenditure−0.0Free cash flow−7.1Fiscal year 2025Operating cash flow−8.0Capital expenditure−0.0Free cash flow−8.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −7.8 −9.5 −7.5 −8.6 −8.8 −11.9 −12.1 −10.7 −7.1 −8.0
Capital expenditure −0.0 −0.2 −0.0 −0.1 −0.0 −0.1 −0.1 −0.0 −0.0 −0.0
Free cash flow −7.8 −9.7 −7.5 −8.7 −8.8 −11.9 −12.3 −10.8 −7.1 −8.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash12.9Shareholders’ equity10.9Fiscal year 2017Cash3.6Shareholders’ equity1.8Fiscal year 2018Cash14.9Shareholders’ equity13.6Fiscal year 2019Cash7.0Total debt0.0Net cash (debt)7.0Shareholders’ equity5.7Debt to equity0.00Fiscal year 2020Cash14.3Total debt0.2Net cash (debt)14.1Shareholders’ equity13.0Debt to equity0.02Fiscal year 2021Cash24.1Total debt0.0Net cash (debt)24.1Shareholders’ equity21.9Debt to equity0.00Fiscal year 2022Cash11.8Shareholders’ equity10.8Fiscal year 2023Cash8.5Shareholders’ equity7.7Fiscal year 2024Cash5.4Shareholders’ equity4.7Fiscal year 2025Cash21.0Shareholders’ equity20.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 12.9 3.6 14.9 7.0 14.3 24.1 11.8 8.5 5.4 21.0
Total debt n/a n/a n/a 0.0 0.2 0.0 n/a n/a n/a n/a
Net cash (debt) n/a n/a n/a 7.0 14.1 24.1 n/a n/a n/a n/a
Shareholders’ equity 10.9 1.8 13.6 5.7 13.0 21.9 10.8 7.7 4.7 20.1
Debt to equity n/a n/a n/a 0.00 0.02 0.00 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Assets
12.9 3.6 14.9 7.0 14.3 24.1 11.8 8.5 5.4 21.0
0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0
13.4 4.1 15.3 8.0 15.7 25.2 12.8 9.4 5.7 21.5
Growth −69.4% +273.9% −47.5% +95.8% +59.9% −49.1% −26.9% −38.7% +274.5%
Liabilities
n/a n/a n/a 0.0 0.2 0.0 n/a n/a n/a n/a
calc n/a n/a n/a 0.0 0.2 0.0 n/a n/a n/a n/a
n/a n/a 1.7 2.3 2.7 3.2 2.0 1.6 1.0 1.3
Equity
−66.1 −78.6 −85.9 −94.8 −103.6 −116.9 −128.4 −139.2 −146.4 −155.1
10.9 1.8 13.6 5.7 13.0 21.9 10.8 7.7 4.7 20.1
Growth −83.1% +640.8% −57.7% +126.5% +68.5% −50.6% −28.7% −38.9% +326.6%
Per share and net cash
calc n/a n/a n/a 7.0 14.1 24.1 n/a n/a n/a n/a
1.3 2.4 0.3 0.7 5.8 1.1 1.1 0.4 1.7 11.6
calc 8.35 0.75 39.63 8.59 2.25 19.44 9.52 18.57 2.72 1.73

† The diluted share count jumps at 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.